Editorial
Shared governance of international myositis networks
T. Liewluck1, L.G. Rider2, K. Cheng3, H. Chinoy4, M.M. Dimachkie5, E. Dourado6, P.C. Gandiga7, D.A. Isenberg8, K. Ardalan9, S. Keret10, S. Kim11, P. Korsten12, I.E. Lundberg13, P.M. Machado14, F.W. Miller15, C. Papadopoulou16, S. Rosina17, L.A. Saketkoo18, S. Schlüter19, J. Vencovský20, A.J. Van Der Kooi21, J. Schmidt22
- Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic, Rochester, MN, USA.
- Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
- International Myositis Society, Göttingen, Germany (representing Patient Advocacy Organizations, PAO); and Patient Advisory Board, Myositis International Health and Research Alliance, New Orleans, LA, USA.
- National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester; and Department of Rheumatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.
- Neuromuscular Division, Neurology Department, The University of Kansas Medical Center, Kansas City, KS, USA.
- Rheumatology Department, Unidade Local de Saúde da Região de Aveiro; Aveiro Rheumatology Research Centre, Egas Moniz Health Alliance, Aveiro; and Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal.
- Division of Rheumatology, Emory University, Atlanta, GA, USA.
- Centre for Rheumatology, Division of Medicine, University College London Hospital, London, UK.
- Department of Paediatrics, Division of Paediatric Rheumatology, Duke University School of Medicine, Durham, NC, USA.
- Rheumatology Unit, Bnai Zion Medical Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
- Department of Paediatric Rheumatology, UCSF Medical School, San Francisco, CA, USA.
- Department of Rheumatology and Clinical Immunology, St. Josef-Stift Sendenhorst, Sendenhorst, Germany.
- Division of Rheumatology, Department of Medicine, Solna Karolinska Institutet, Stockholm; and Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging,Karolinska University Hospital, Stockholm, Sweden.
- Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.
- Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
- Rheumatology Department, Great Ormond Street Hospital for Children NHS Foundation Trust and Great Ormond Street Institute of Child Health, University College London, UK.
- UOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genova, Italy.
- New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University and Tulane University Schools of Medicine, New Orleans, LA, USA.
- Myositis-Gruppe, Deutsche Gesellschaft für Muskelkranke, Freiburg, Germany; International Myositis Society, Göttingen, Germany (representing Patient Advocacy Organizations, PAO).
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Department of Neurology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Department of Neurology, Neuromuscular Center, University Medical Center Göttingen; and Department of Neurology and Pain Treatment, Immanuel University Hospital Rüdersdorf, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany. j.schmidt@gmx.org
CER19373
2026 Vol.44, N°2
PI 0178, PF 0185
Editorial
Free to view
(click on article PDF icon to read the article)
PMID: 41738253 [PubMed]
Received: 01/10/2025
Accepted : 30/01/2026
In Press: 24/02/2026
Published: 24/02/2026
